WORLD TRADE
ORGANIZATIONG/TBT/Notif.00/369
22 August 2000
(00-3356)
Committee on Technical Barriers to Trade
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6.
1. Member to Agreement notifying:   REPUBLIC OF KOREA
If applicable, name of local government involved (Articles 3.2 and 7.2):           
2. Agency responsible:   Korea Food and Drug Administration
Agency or authority designated to handle comments regarding the notification shall be
indicated if different from above:           
3. Notified under Article 2.9.2 [ X ], 2.10.1 [    ], 5.6.2 [    ], 5.7.1 [    ], other:           
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading.
ICS numbers may be provided in addition, where applicable):   Medicines
5. Title, number of pages and language(s) of the notified document:   Public Notification of
Draft Enactment of "The Regulation of Package Labeling and Marking on Medicines"
(2 pages)
6. Description of content:   This enactment is to assure the appropriate usage of medicine by
designating the subjects and the method of individual tablet/capsule marking, and thelabeling contents on the package of the grouped tablets/capsules.
- Each medicine must be distinguished from others by having numbers or characters
marked on each tablet or capsule and having product's name and manufacturer labelled on
package of every two of four tablets or capsules.
7. Objective and rationale, including the na ture of urgent problems where applicable:   
Human health
8. Relevant documents:   KFDA notification 2000-40 (16 June 2000)
9. Proposed date of adoption:  August 2000
Proposed date of entry into force:  1 January 2001          
10. Final date for comments:   September 2000
11. Texts available from:  National enquiry point [     ] or address, e-mail and telefax
number of the other body:
Pharmaceutical Surveillance Division
Korea Food and Drug Administration
#5, Nokbun-dong, Eunpyung-kuSeoul
Korea 122-020
Tel:  +82-2-380-1658 Fax:  +82-2-383-2870